Sign Up to like & get
recommendations!
1
Published in 2018 at "Mycoses"
DOI: 10.1111/myc.12731
Abstract: Isavuconazole is a novel antifungal drug approved for the treatment of adults with invasive aspergillosis and mucormycosis. While azoles as a class effect are known to prolong QTc interval, clinical trials have shown that isavuconazole…
read more here.
Keywords:
isavuconazole shortens;
qtc interval;
shortens qtc;
treatment ... See more keywords